Over 60 HKAPI members attended our webinar on 28 May where subject matter experts from the Drug Enlistment Task Force provide updates on the current HA drug enlistment system as well as the Macao enlistment system.
Task Force Deep Dive: Affordability & Public-Private Partnership Based on the post-event survey of 2021 AGM, members would like to have deep-dive sessions for functional managers with some task forces. Therefore, […]
Our task force leads Karen Yuen and Sui Wong joined the “World Rare Disease Day 2020 Online Symposium” organized by Rare Disease Hong Kong (RDHK), formerly known as “Hong Kong Alliance for Rare Diseases (HKARD)”.
HKAPI statement on Novel Coronavirus The Hong Kong Association of the pharmaceutical Industry (HKAPI) representing 34 R&D multinational pharmaceutical companies in Hong Kong, providing 70% of prescription medicine in Hong […]
Over 250 guests from the academia, healthcare professionals, our trade partners and the government’s medical top policymakers and administrators attended the Hong Kong Association of the Pharmaceutical Industry Annual Dinner 2019.